[1. Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21:271-6.10.1007/s11239-006-5709-z]Search in Google Scholar
[2. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282: 2019-26.10.1001/jama.282.21.2019]Search in Google Scholar
[3. Clark WM, Albers GW, Madden KP, Hamilton S. Thromblytic therapy in acute ischemic stroke study investigators. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke. 2000; 31:811-6.10.1161/01.STR.31.4.811]Search in Google Scholar
[4. Hacke W, Kaste M, Fieschi C, at al. Second European- Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of Thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-51.10.1016/S0140-6736(98)08020-9]Search in Google Scholar
[5. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-25.10.1001/jama.1995.03530130023023]Search in Google Scholar
[6. The National Institute of Neurological Disorders and Stroke rt- PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-7.10.1056/NEJM199512143332401]Search in Google Scholar
[7. Actilyse. European Agency for the Evaluation of Medicinal products. Available at web site: http://emc.medicines.org.uk/ emc/assets/c/html/displaydoc.asp?documentid_308. Accessed February 20, 2007.]Search in Google Scholar
[8. Kittner SJ, Stern BJ, Feeser BR. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768-74.10.1056/NEJM199609123351102]Search in Google Scholar
[9. Qureshi AI. Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet. 2004;363:804-13.10.1016/S0140-6736(04)15697-3]Search in Google Scholar
[10. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke. 1998;29:2568-74.10.1161/01.STR.29.12.2568]Search in Google Scholar
[11. Ramee SR, Subramanian R, Felberg RA, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke. 2004;35:e109-11.10.1161/01.STR.0000125711.94465.7815087568]Search in Google Scholar
[12. Jaigobin C, Silver FL. Stroke and pregnancy. Stroke. 2000;31:2948- 51.10.1161/01.STR.31.12.294811108754]Search in Google Scholar
[13. Cross JN, Castro PO, Jennett WB. Cerebral strokes associated with pregnancy and the puerperium. BMJ. 1968;3:214-18.10.1136/bmj.3.5612.21419862325662974]Search in Google Scholar
[14. Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A, Pezzini A. Ischemic Stroke during Pregnancy and Puerperium. Stroke Res Treat. 2011;2011:606780.10.4061/2011/606780303867921331336]Search in Google Scholar
[15. Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke. 2005;36:e53-5.10.1161/01.STR.0000166203.27135.27]Search in Google Scholar
[16. Li Y, Margraf J, Kluck B, Jenny D, Castaldo J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review. Neurologist. 2012;18:44-8.10.1097/NRL.0b013e31823d7af022217616]Search in Google Scholar
[17. Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke. 2006;37:2168-9.10.1161/01.STR.0000230286.95513.c216794210]Search in Google Scholar
[18. Yamaguchi Y, Kondo T, Ihara M, Kawamata J, Fukuyama H, Takahashi R. Intravenous recombinant tissue plasminogen activator in an 18-week pregnant woman with embolic stroke. Abstract. Rinsho Shinkeigaku. 2010;50:315-9.10.5692/clinicalneurol.50.31520535980]Search in Google Scholar
[19. Tassi R, Acampa M, Marotta G, et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med. 2013;31:448.e1-3.10.1016/j.ajem.2012.05.04022867835]Search in Google Scholar
[20. Elford K, Leader A, Wee R, Stys PK. Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology. 2002;59:1270-2.10.1212/01.WNL.0000032492.77156.35]Search in Google Scholar
[21. De Keyser J, Gdovinová Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612-8.10.1161/STROKEAHA.106.48056617656661]Search in Google Scholar